4//SEC Filing
Lurker Nancy 4
Accession 0001450485-25-000009
CIK 0001314102other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:06 PM ET
Size
6.7 KB
Accession
0001450485-25-000009
Insider Transaction Report
Form 4
Lurker Nancy
Director
Transactions
- Sale
Common Stock
2025-12-04$15.11/sh−9,300$140,477→ 206,547 total
Holdings
- 126,889(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.95 to $15.36. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. average price.
- [F2]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001450485
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:06 PM ET
- Size
- 6.7 KB